Anna M. Suszczak-Serwotka
Duńska St 11
Wroclaw, DS 54427, Poland
Wroclaw, DS 54427, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Targeted degradation of GSPT1 and NEK7 by a molecular glue prodrug for treatment of HCC.
Journal: Communications chemistry
Published: March 17, 2025
Sex Hormone-Binding Globulin (SHBG) Maintains Proper Equine Adipose-Derived Stromal Cells (ASCs)' Metabolic Functions and Negatively Regulates their Basal Adipogenic Potential.
Journal: Stem cell reviews and reports
Published: June 17, 2023
The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver through Anti-Inflammatory and Antifibrotic Activity.
Journal: International journal of inflammation
Published: February 01, 2023
The PTP1B inhibitor MSI-1436 ameliorates liver insulin sensitivity by modulating autophagy, ER stress and systemic inflammation in Equine metabolic syndrome affected horses.
Journal: Frontiers in endocrinology
Published: January 22, 2023
In Vitro Generated Equine Hepatic-Like Progenitor Cells as a Novel Potent Cell Pool for Equine Metabolic Syndrome (EMS) Treatment.
Journal: Stem cell reviews and reports
Published: January 11, 2023
Synergistic Effect of Toceranib and Nanohydroxyapatite as a Drug Delivery Platform-Physicochemical Properties and In Vitro Studies on Mastocytoma Cells.
Journal: International journal of molecular sciences
Published: December 30, 2021
Nanohydroxyapatite-Mediated Imatinib Delivery for Specific Anticancer Applications.
Journal: Molecules (Basel, Switzerland)
Published: September 09, 2020
The Haematococcus pluvialis extract enriched by bioaccumulation process with Mg(II) ions improves insulin resistance in equine adipose-derived stromal cells (EqASCs).
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 07, 2019
Correction: Serwotka-Suszczak, A. M. et al. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells. Int. J. Mol. Sci. 2017, 18, 401.
Journal: International journal of molecular sciences
Published: November 08, 2018
A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells.
Journal: International journal of molecular sciences
Published: December 14, 2016
A Novel Affibody-Auristatin E Conjugate With a Potent and Selective Activity Against HER2+ Cell Lines.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: May 27, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026